Quaker Houghton <KWR.N>: Truist Securities raises target price to $190 from $172
KWR•Related News
VirTra sets conference call to discuss Q2 results
VTSI•
Acurx says FDA open to single Phase 3 trial to support ibezapolstat CDI NDA filing
ACXP•
Taysha Gene Therapies signs commercial supply deal with Catalent for TSHA-102 Rett syndrome therapy
TSHA•
Rivian <RIVN.O>: D.A. Davidson raises target price to $17 from $15
RIVN•
Cohen & Company Q2 revenue rises on investment banking, trading strength
COHN•